0 U.S. approves GSK’s ViiV Healthcare’s new HIV treatment February 2, 2022 admin United States (U.S.) HIV specialist pharmaceutical company, ViiV Healthcare on Wednesday said that the U.S. Food and Drug Administration (FDA) has approved Cabenuva cabotegravir and rilpivirine for